Court triples Olden/Interpharm award to Ukraine's Ukrvaktsina to $60 million
This article was originally published in Scrip
Executive Summary
The Oregon district court has updated its verdict in the Ukrvaktsina vs Olden Group/Interpharm case tripling to almost $60 million the payment that defenders should return to Ukraine's state budget. The court ruled on 20 May that Olden Group/Interpharm would return $19 million earned illegally through a drug price inflation fraud (scripintelligence.com, 31 May 2011).